Promising HIV-prevention drug lenacapavir is hard to find in Africa and beyond as demand outstrips supply
Summary
A promising drug that offers complete protection against HIV and requires only two shots a year is not getting to enough people, experts say, ABC News and The Philadelphia Inquirer reported on Tuesday 3 November, headlining that the drug is hard to find where it is most needed. Demand for lenacapavir is far outstripping supply in Uganda, other parts of Africa and all over the world, PBS NewsHour reported, adding that U.S. regulators on Monday approved a generic version for sale in low-income countries.
Latest: A promising drug that offers complete protection against HIV and requires only two shots a year is not getting to enough people, experts say, ABC News and The Philadelphia Inquirer reported, PBS NewsHour writing that demand for lenacapavir is far outstripping supply and that U.S. regulators on Monday approved a generic version for sale in low-income countries.
Written automatically by an AI from the articles' headlines and descriptions. It can contain errors: follow the links to read the articles.
How it unfolded
Tuesday 3 November
A promising drug that offers complete protection against HIV and requires only two shots a year is not getting to enough people, experts say, ABC News and The Philadelphia Inquirer reported, PBS NewsHour writing that demand for lenacapavir is far outstripping supply and that U.S. regulators on Monday approved a generic version for sale in low-income countries.
- 11:01PBS NewsHour A new HIV-prevention drug is showing promising signs, but it's difficult to find in Africa and beyond
- 11:00The Philadelphia Inquirer A promising new drug could turn the tide against HIV. But it's hard to find where it's needed most
- 03:14ABC News Promising new HIV-prevention drug is hard to find where it's most needed
- 03:06The Philadelphia Inquirer Promising new HIV-prevention drug is hard to find where it's most needed, in places like Uganda